Evaxion A (EVAX) Payables (2019 - 2025)
Evaxion A (EVAX) posted Payables of $2.2 million for Q4 2025, down 39.73% on a QoQ basis from $3.6 million in Q2 2025, and down 26.35% year-over-year from $3.0 million in Q4 2024.
Evaxion A (EVAX) Payables (2019 - 2025) Analysis & Trends
Evaxion A's Payables history runs 7 years deep, the most recent figure standing at $2.2 million for Q4 2025.
- Quarterly Payables fell 26.35% year-over-year to $2.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.2 million (down 26.35% YoY) and the FY2025 annual result came in at $2.2 million, down 26.35% from the prior year.
- Payables was $2.2 million for Q4 2025 at Evaxion A, down from $3.6 million in the prior quarter.
- Across five years, Payables topped out at $5.4 million in Q4 2023 and bottomed at $538000.0 in Q3 2021.
- A 5-year average of $2.6 million and a median of $2.5 million in 2022 frame the typical range for Payables.
- Annual changes were most pronounced in 2023 — Payables surged 159.14% — and 2024, when it slumped 45.07%.
- Evaxion A's Payables stood at $2.8 million in 2021, then retreated by 26.79% to $2.1 million in 2022, then soared by 159.14% to $5.4 million in 2023, then plunged by 45.07% to $3.0 million in 2024, then declined by 26.35% to $2.2 million in 2025.
- Business Quant data shows EVAX's Payables at $2.2 million in Q4 2025, $3.6 million in Q2 2025, and $3.0 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 10.62 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 8.69 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 423.55 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 80.54 Mn |
| 10 | Evaxion A | 1.23 Bn | 1.23 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.19 Mn |
| Jun 30, 2025 | 3.63 Mn |
| Dec 31, 2024 | 2.97 Mn |
| Jun 30, 2024 | 2.56 Mn |
| Dec 31, 2023 | 5.40 Mn |
| Jun 30, 2023 | 1.69 Mn |
| Dec 31, 2022 | 2.09 Mn |
| Jun 30, 2022 | 2.44 Mn |
| Mar 31, 2022 | 2.49 Mn |
| Dec 31, 2021 | 2.85 Mn |
| Sep 30, 2021 | 538,000.00 |
| Jun 30, 2021 | 1.55 Mn |
| Mar 31, 2021 | 3.41 Mn |
| Dec 31, 2020 | 3.67 Mn |
| Dec 31, 2019 | 646,000.00 |